Keyphrases
Cerebrospinal Fluid
100%
Amprenavir
100%
IC50
18%
Fosamprenavir
18%
Liquid Chromatography-tandem Mass Spectrometry (LC-MS/MS)
9%
Central Nervous System
9%
Prodrug
9%
Middle-aged
9%
HIV-1 Replication
9%
High-performance Liquid Chromatography
9%
High Concentration
9%
Antiretroviral
9%
Neurocognitive Function
9%
Plasma Concentration
9%
Antiretroviral Regimens
9%
50% Inhibitory Concentration
9%
Therapeutic Range
9%
Cerebrospinal Fluid Concentration
9%
Sampling Interval
9%
Agricultural and Biological Sciences
Cerebrospinal Fluid
100%
Amprenavir
100%
Blood Plasma
41%
Human Immunodeficiency Virus
33%
Liquid Chromatography-Mass Spectrometry
16%
Fosamprenavir
16%
Central Nervous System
8%
High-Performance Liquid Chromatography
8%
Inhibitory Concentration 50
8%
Neuroscience
Amprenavir
100%
Blood Plasma
71%
Human Immunodeficiency Virus
57%
Liquid Chromatography-Mass Spectrometry
28%
Fosamprenavir
28%
Central Nervous System
14%
Prodrug
14%
Immunology and Microbiology
Cerebrospinal Fluid
100%
Human Immunodeficiency Virus
36%
Blood Plasma
27%
IC50
27%
Wild Type
18%
High Performance Liquid Chromatography
9%
Central Nervous System
9%
Tandem Mass Spectrometry
9%
Blood Level
9%
Liquid Chromatography Tandem Mass Spectrometry
9%
Cerebrospinal Fluid-to-Plasma Ratio
9%
Pharmacology, Toxicology and Pharmaceutical Science
Amprenavir
100%
HIV
57%
IC50
42%
Fosamprenavir
28%
High Performance Liquid Chromatography
14%
Prodrug
14%
Veterinary Science and Veterinary Medicine
Cerebrospinal Fluid
100%
Blood Plasma
41%
Central Nervous System
8%